Related references
Note: Only part of the references are listed.Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology
Jesmond Dalli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair
Wenting Yang et al.
NATURE COMMUNICATIONS (2019)
Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis
Magdalena B. Flak et al.
JCI INSIGHT (2019)
Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
Romain A. Colas et al.
CIRCULATION RESEARCH (2018)
Biosynthesis of D-Series Resolvins in Skin Provides Insights into their Role in Tissue Repair
Jason Hellmann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
Mary E. Walker et al.
FASEB JOURNAL (2017)
Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling
Miguel Quiros et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Location in the spleen dictates the function of murine neutrophils
Patrizia Scapini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia
J. M. Lanis et al.
MUCOSAL IMMUNOLOGY (2017)
Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection
Thomas Gobbetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
Jesmond Dalli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Neutrophil interactions with epithelial-expressed ICAM-1 enhances intestinal mucosal wound healing
R. Sumagin et al.
MUCOSAL IMMUNOLOGY (2016)
K/BxN Serum-Transfer Arthritis as a Model for Human inflammatory Arthritis
Anne D. Christensen et al.
FRONTIERS IN IMMUNOLOGY (2016)
Identification of resolvin D2 receptor mediating resolution of infections and organ protection
Nan Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Gigantism, Acromegaly, and GPR101 Mutations
Peter Kamenicky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis
Ehud Zigmond et al.
IMMUNITY (2014)
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
G. Trivellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
Jesmond Dalli et al.
CHEMISTRY & BIOLOGY (2013)
New learnings on the pathophysiology of RA from synovial biopsies
Costantino Pitzalis et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Novel n-3 Immunoresolvents: Structures and Actions
Jesmond Dalli et al.
SCIENTIFIC REPORTS (2013)
Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators
Jesmond Dalli et al.
BLOOD (2012)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Matthew Spite et al.
NATURE (2009)
Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity
Matthew F. Peters et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
β galactosidase complementation:: A cell-based luminescent assay platform for drug discovery
Keith R. Olson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2007)
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
M Perretti et al.
NATURE MEDICINE (2002)
Share Paper
